From Our Readers

From Our Readers

Severe macrocytic anemia in a patient with CMML-1

Saturday, March 11th, 2017
Here's how readers responded to a Consult-a-Colleague question about the management of severe macrocytic anemia in a 73-year-old male patient with chronic myelomonocytic leukemia-1.You Made...

Not-So-NICE One

Wednesday, March 1st, 2017
In December 2016, we published an Online Exclusive item reporting on the United Kingdom’s National Institute for Health and Care Excellence’s (NICE) review of...

Another Clinical Research Secret

Thursday, February 2nd, 2017
In the December 2016 Editor’s Corner (“So You Say You Want to Be a Clinical Researcher?”), Mikkael A. Sekeres, MD, MS, offered advice for...

Marrow-Minded

Wednesday, January 25th, 2017
In November’s Editor’s Corner, David Steensma, MD, recounted the “absurdly exotic experience” of eating bone marrow in a café in Milan after speaking about...

Understanding Those Who Actually Insert Inferior Vena Cava Filters

Monday, January 23rd, 2017
To The Editor: As an interventional radiologist who specializes in acute and chronic deep-vein thrombosis (DVT), superficial venous disease, and complex filter removal, I applaud...

A Response on Email Etiquette

Sunday, January 22nd, 2017
In October’s Editor’s Corner, Editor-in-Chief Mikkael A. Sekeres, MD, MS, and his colleague at Cleveland Clinic, Jennifer Lonzer, MA, provided “A Primer on Email...

The Family That Puzzles Together …

Tuesday, January 17th, 2017
In December’s issue, Associate Editor David Steensma, MD, shared his lifelong love of word games, and how he went from fighting over the newspaper...

Learning Your ABC

Thursday, January 12th, 2017
In September’s Editor’s Corner, Keith Stewart, MBChB, MBA, argued that cytotoxic chemotherapy should be declared a thing of the past and imagined a future...

How long should a patient continue anticoagulation and should she continue during pregnancy?

Sunday, January 1st, 2017
Here's how readers responded to a Consult-a-Colleague question about anticoagulation during pregnancy. First, although I don’t disagree with rivaroxaban in this case, it has neither...

The Roadmap Forward in Follicular Lymphoma: Time for a Precision Approach

Wednesday, December 7th, 2016
Over the past two decades, improved diagnostic accuracy and novel therapeutic approaches have resulted in profound improvements in overall survival in patients with follicular...
Advertisement

Current Issue

March 2017, Volume 3, Issue 4

This issue takes a look at diversity in the medical education system, provides a hematology drug pipeline update, and more.